Hemodynamic performance of self-expandable transcatheter aortic valve replacement systems during valve deployment.

Transcatheter heart valve aortic stenosis self-expandable transcatheter heart valve transcatheter aortic valve replacement (TAVR) valve hemodynamic performance

Journal

The Journal of invasive cardiology
ISSN: 1557-2501
Titre abrégé: J Invasive Cardiol
Pays: United States
ID NLM: 8917477

Informations de publication

Date de publication:
13 Mar 2024
Historique:
medline: 15 3 2024
pubmed: 15 3 2024
entrez: 15 3 2024
Statut: aheadofprint

Résumé

Little is known about valve hemodynamic performance during the Evolut and Neo deployment course. We aimed to evaluate transvalvular mean and peak-to-peak gradients over several intraprocedural timepoints during TAVR with Evolut PRO+ (Medtronic) and Neo (Boston Scientific) systems. This was single-center pilot sub-study from the SavvyWire EFficacy and SafEty in Transcatheter Aortic Valve Implantation Procedures (SAFE-TAVI) trial. Participants received either the Evolut PRO+ or Neo for native valve severe aortic stenosis and the SavvyWire (OpSens Medical) was used for device delivery, pacing, and continuous left ventricular and aortic pressure measurements. For the Evolut, evaluation was done for baseline, two-thirds of valve deployment (still recapturable), 90% of valve deployment (no longer recapturable), and post-deployment hemodynamics. For the Neo, analysis was done at baseline, after the first step (top-crown deployment), and at final status. Nineteen patients were included (Evolut = 15; Neo = 4). There were no statistically significant changes in peak-to-peak gradients (44 mm Hg [IQR:33-69] vs 43 mm Hg [IQR:26-62], P = .41) between baseline and two-thirds of valve deployment in the Evolut patients. There was a significant decrease in mean (40 mm Hg [IQR:32-54] vs 14 mm Hg [IQR:10-18], P less than .001) and peak-to-peak (43 mmHg [IQRS:26-62] vs 9 mm Hg [IQR:8-13], P less than .001) transvalvular gradients between two-thirds and 90% of valve deployment for Evolut. Neo patients exhibited a decrease in transvalvular gradients after top-crown deployment (42.5 mm Hg baseline vs 13 mm Hg). Transvalvular gradients did not vary between the point of "no-recapture" compared to baseline values in patients receiving the Evolut, whereas a significant reduction in transvalvular gradients was observed when the valve was deployed at 90% and fully deployed. The Neo valve was slightly obstructive after the first step of deployment.

Identifiants

pubmed: 38489568
doi: 10.25270/jic/23.00286
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Auteurs

Alberto Alperi (A)

University Hospital of Asturias, Oviedo, Asturias, Spain; Instituto de Investigación Sanitaria del Principado de Asturias, Spain.

Cesar Moris (C)

University Hospital of Asturias, Oviedo, Asturias, Spain; Instituto de Investigación Sanitaria del Principado de Asturias, Spain; University of Oviedo, Asturias, Spain.

Raquel Del Valle (R)

University Hospital of Asturias, Oviedo, Asturias, Spain.

Isaac Pascual (I)

University Hospital of Asturias, Oviedo, Asturias, Spain; Instituto de Investigación Sanitaria del Principado de Asturias, Spain; University of Oviedo, Asturias, Spain.

Paula Antuna (P)

University Hospital of Asturias, Oviedo, Asturias, Spain.

Marcel Almendárez (M)

University Hospital of Asturias, Oviedo, Asturias, Spain.

Daniel Hernández-Vaquero (D)

University Hospital of Asturias, Oviedo, Asturias, Spain; Instituto de Investigación Sanitaria del Principado de Asturias, Spain.

Jose Luis Betanzos (JL)

University Hospital of Asturias, Oviedo, Asturias, Spain.

Josep Rodés-Cabau (J)

Quebec Heart and Lung Institute, Laval University, Quebec City, Quebec, Canada.

Pablo Avanzas (P)

University Hospital of Asturias, Oviedo, Asturias, Spain; Instituto de Investigación Sanitaria del Principado de Asturias, Spain; University of Oviedo, Asturias, Spain; Centro de Investigación en Red de Enfermedades Cardiovasculares (CIBERCV). Email: avanzas@secardiologia.es; avanzaspablo@uniovi.es; avanzas@gmail.com.

Classifications MeSH